- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Hong Kong Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Results
120
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
120 companies
Cloudbreak Pharma
Market Cap: HK$5.0b
A clinical-stage ophthalmology biotechnology company, researches and develops ophthalmic drugs for chronic eye diseases.
2592
HK$5.75
7D
-17.5%
1Y
n/a
Zhaoke Ophthalmology
Market Cap: HK$1.7b
An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, Hong Kong, and internationally.
6622
HK$3.02
7D
-2.9%
1Y
134.1%
Shanghai Junshi Biosciences
Market Cap: HK$35.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$23.24
7D
-3.2%
1Y
89.9%
Sanai Health Industry Group
Market Cap: HK$75.7m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.49
7D
-2.9%
1Y
19.3%
Sino Biopharmaceutical
Market Cap: HK$116.0b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$6.57
7D
-3.4%
1Y
104.7%
China Traditional Chinese Medicine Holdings
Market Cap: HK$10.9b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.18
7D
-0.9%
1Y
-4.0%
3SBio
Market Cap: HK$63.4b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$26.16
7D
-6.0%
1Y
332.4%
Sunshine Lake Pharma
Market Cap: HK$25.5b
Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.
6887
HK$44.56
7D
5.2%
1Y
20.9%
Kintor Pharmaceutical
Market Cap: HK$942.6m
A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China.
9939
HK$1.94
7D
-2.0%
1Y
100.0%
Frontage Holdings
Market Cap: HK$2.1b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.01
7D
0%
1Y
-39.2%
Lepu Biopharma
Market Cap: HK$9.3b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of first-in class and best-in-class drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally.
2157
HK$5.43
7D
1.7%
1Y
82.2%
VISEN Pharmaceuticals
Market Cap: HK$3.8b
An investment holding company, engages in the development and commercialization of paradigm-shifting endocrine therapies in the Chinese Mainland.
2561
HK$35.50
7D
-7.8%
1Y
n/a
TransThera Sciences (Nanjing)
Market Cap: HK$66.7b
TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.
2617
HK$163.90
7D
2.0%
1Y
n/a
CF PharmTech
Market Cap: HK$14.1b
Engages in research and development, production, and sale of respiratory drugs in the field of respiratory diseases in China.
2652
HK$34.86
7D
-1.9%
1Y
n/a
Essex Bio-Technology
Market Cap: HK$2.2b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$3.90
7D
-0.3%
1Y
40.3%
Duality Biotherapeutics
Market Cap: HK$27.4b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$336.60
7D
3.2%
1Y
n/a
Luye Pharma Group
Market Cap: HK$11.3b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.88
7D
-2.0%
1Y
34.6%
Shanghai Henlius Biotech
Market Cap: HK$32.9b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$62.55
7D
-3.5%
1Y
161.7%
Sirnaomics
Market Cap: HK$859.7m
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.
2257
HK$8.27
7D
-8.8%
1Y
142.5%
Guangzhou Innogen Pharmaceutical Group
Market Cap: HK$14.1b
Engages in development of drugs.
2591
HK$33.32
7D
-2.5%
1Y
n/a
RemeGen
Market Cap: HK$47.0b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$78.30
7D
-0.9%
1Y
430.5%
Hansoh Pharmaceutical Group
Market Cap: HK$235.9b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$38.50
7D
-10.5%
1Y
114.6%
JW (Cayman) Therapeutics
Market Cap: HK$1.1b
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$2.71
7D
-11.1%
1Y
111.7%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.2b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.51
7D
-1.2%
1Y
0.6%
Regent Pacific Group
Market Cap: HK$286.0m
An investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.
575
HK$0.98
7D
-10.9%
1Y
164.9%
PegBio
Market Cap: HK$17.8b
A biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China.
2565
HK$63.00
7D
-2.9%
1Y
n/a
Brii Biosciences
Market Cap: HK$1.1b
Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$1.54
7D
-1.9%
1Y
81.2%
Modern Chinese Medicine Group
Market Cap: HK$381.6m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.52
7D
4.0%
1Y
23.8%
Fujian Haixi Pharmaceuticals
Market Cap: HK$10.4b
Manufactures and sells pharmaceutical drugs in China.
2637
HK$132.80
7D
0.4%
1Y
n/a
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$2.6b
A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.
1541
HK$6.24
7D
-4.0%
1Y
24.1%
Vigonvita Life Sciences
Market Cap: HK$5.5b
A commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas.
2630
HK$82.05
7D
11.8%
1Y
n/a
Tong Ren Tang Technologies
Market Cap: HK$5.7b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.49
7D
-1.8%
1Y
-10.4%
Immunotech Biopharm
Market Cap: HK$1.7b
A cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China.
6978
HK$2.88
7D
-3.0%
1Y
23.1%
Antengene
Market Cap: HK$2.7b
A clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.
6996
HK$4.05
7D
-8.0%
1Y
542.9%
Abbisko Cayman
Market Cap: HK$8.9b
Engages in the research and development of pharmaceutical products in the People’s Republic of China and the European Union.
2256
HK$13.48
7D
-5.9%
1Y
210.6%
Jacobio Pharmaceuticals Group
Market Cap: HK$7.0b
An investment holding company, engages in the in-house discovery and development of oncology therapies.
1167
HK$9.06
7D
-0.5%
1Y
602.3%